{"id":"NCT00491530","sponsor":"Abbott","briefTitle":"A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia","officialTitle":"A Year 2, Long-Term, Open-Label, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2007-06-26","resultsPosted":"2009-12-07","lastUpdate":"2012-01-20"},"enrollment":310,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mixed Dyslipidemia"],"interventions":[{"type":"DRUG","name":"ABT-335","otherNames":["fenofibric acid"]},{"type":"DRUG","name":"rosuvastatin calcium","otherNames":["Crestor"]},{"type":"DRUG","name":"simvastatin","otherNames":["Zocor"]},{"type":"DRUG","name":"atorvastatin calcium","otherNames":["Lipitor"]}],"arms":[{"label":"ABT-335 + rosuvastatin calcium","type":"EXPERIMENTAL"},{"label":"ABT-335 + simvastatin","type":"EXPERIMENTAL"},{"label":"ABT-335 + atorvastatin calcium","type":"EXPERIMENTAL"}],"summary":"The objective of the study is to assess the continued safety of the daily coadministration of ABT-335 in combination with rosuvastatin calcium, simvastatin or atorvastatin calcium.","primaryOutcome":{"measure":"Percentage of Subjects Reporting Adverse Events During Combination Therapy in the Preceding Double-Blind Studies or in the Preceding Open-Label Year 1 Study or in This Open-Label Year 2 Study","timeFrame":"Anytime after initiation of combination therapy (in the preceding 12-week double-blind studies or in the preceding open-label year 1 study) up to 116 weeks, to within 30 days after the last dose of combination therapy.","effectByArm":[{"arm":"ABT-335 + 20 mg Rosuvastatin","deltaMin":94.8,"sd":null},{"arm":"ABT-335 + 40 mg Simvastatin","deltaMin":90,"sd":null},{"arm":"ABT-335 + 40 mg Atorvastatin","deltaMin":97.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["19995098"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":174},"commonTop":["Upper respiratory tract infection","Headache","Back pain","Bronchitis","Nasopharyngitis"]}}